MoonLake Immunotherapeutics

MLTX

Equity

ISIN KY61559X1045 / Valor 118139749

NASDAQ (2026-01-23)

USD 15.86+1.54%

MoonLake Immunotherapeutics
UMushroom community rating:

4.00 2 votes No rating yet

NegativeNeutralPositive

About company

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory diseases. The company's primary asset is Sonelokimab, an investigational Nanobody® designed to target and treat inflammation more effectively. By leveraging advanced biotechnological approaches, MoonLake aims to improve patient outcomes in conditions characterized by chronic inflammation. The company is dedicated to advancing Sonelokimab through clinical trials to establish its efficacy and safety, positioning itself as a key player in the biopharmaceutical industry’s efforts to address unmet medical needs in inflammatory diseases.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-66.2%1Y

38.0%3Y

%5Y

Performance

240%1Y

153%3Y

148%5Y

Volatility

1010 M

Market cap (USD)

1,349,048

Daily traded volume (Shares)

55.19 / 52.6

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

2 votes

Performance:

4.50

Innovation:

4.00

Society:

4.00

Nature:

4.00

Alex Roberts

United Kingdom, 17 Dec 2025

Should've listened to this guy -->

Alex Roberts

United Kingdom, 20 Nov 2025

up 40% since I added a month ago, bounce back after potential lawsuit. Potential takeover looming

EQUITIES OF THE SAME SECTOR

Covivio SA

Covivio SA Valor: 513056

Annual Return

-50%0%+50%

Risk level

110

-0.37%EUR 53.20

SCOR SE

SCOR SE Valor: 2844943

Annual Return

-50%0%+50%

Risk level

110

-0.22%EUR 26.84

mwb fairtrade Wertpapierhandelsbank AG

mwb fairtrade Wertpapierhandelsbank AG Valor: 132210213

Annual Return

-50%0%+50%

Risk level

110

-0.53%EUR 9.35

Wallenstam AB

Wallenstam AB Valor: 118955623

Annual Return

-50%0%+50%

Risk level

110

0.30%SEK 40.46

Peugeot Invest SA

Peugeot Invest SA Valor: 500680

Annual Return

-50%0%+50%

Risk level

110

-0.92%EUR 75.20

Mercialys

Mercialys Valor: 2293301

Annual Return

-50%0%+50%

Risk level

110

-1.13%EUR 10.52

BenevolentAI S.A.

BenevolentAI S.A. Valor: 112417726

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 0.081

Allianz SE

Allianz SE Valor: 322646

Annual Return

-50%0%+50%

Risk level

110

-1.65%EUR 363.90

Deutsche Boerse AG

Deutsche Boerse AG Valor: 1177233

Annual Return

-50%0%+50%

Risk level

110

-0.28%EUR 213.40

Hannover Rueck SE

Hannover Rueck SE Valor: 1115829

Annual Return

-50%0%+50%

Risk level

110

-0.42%EUR 234.40

Logos provided by Clearbit

MoonLake Immunotherapeutics

MLTX

ISIN KY61559X1045 / Valor 118139749

MoonLake Immunotherapeutics UMushroom community rating:

Alex Roberts

Alex Roberts

MoonLake Immunotherapeutics
UMushroom community rating: